Shire plc (SHPG) Tops Q1 EPS Views; Appoints New CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- Cameco Q3 2026 earnings fall on lower Westinghouse income, higher costs
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors
April 30, 2015 7:01 AM EDTDUBLIN, April 30, 2015 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Jeff Poulton as Chief Financial Officer (CFO) and member of the Executive Committee. Jeff will additionally join the Shire Board of Directors. Both appointments are effective immediately.
Jeff has served as Interim CFO since December 2014, while overseeing Investor Relations. As CFO, he will remain based in Lexington. An experienced pharmaceuticals and biotechnology executive, Jeff has extensive experience across financial, commercial and strategic leadership roles. He joined Shire in 2003.
Shire CEO Flemming Ornskov said: "Jeff brings... More
Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS
April 30, 2015 7:01 AM EDTDUBLIN, April 30, 2015 /PRNewswire/ --
- Continued Advancement Toward Goal of Becoming a Leading Global Biotechnology Company Â
Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to March 31, 2015.
Financial Highlights Q1 2015 Growth(1) CER(2) Product sales $1,423 million +9% +13% Total revenues $1,488 million +11% +15% Non GAAP operating income $683 million +16% +19% US GAAP operating income from continuing operations $475 million +55% Non GAAP EBITDA margin (excluding royalties & other revenues)(3) 46% +1pps(4) US GAAP net income margin(5) 28% +11pps Non GAAP diluted earnings per ADS $2.84 +20% +24% US GAAP diluted earnings per ADS $2.08 +77% Non GAAP cash generation $516 million +56% Non GAAP free cash flow... More


